NCT02020330
- Conditions
- Infections, Malaria, Malaria, Falciparum, +5 more
- Locations
-
- Medical Action Myanmar Yangon, Burma
Clinical trial condition
Malaria, Falciparum
Explore clinical trials studying Malaria, Falciparum. Study availability and eligibility vary by location and protocol.
368 public trials
16 recruiting studies
Malaria, Falciparum trial results
Completed
A Microdose Study in Healthy Subjects to Describe Intravenous Pharmacokinetics of GSK3191607
NCT02737007
- Conditions
- Infections, Malaria, Malaria, Falciparum, +4 more
- Locations
-
- GSK Investigational Site London, United Kingdom
NCT01323972
- Conditions
- Infections, Malaria, Malaria, Falciparum, +4 more
- Locations
-
- GSK Investigational Site Enugu, Nigeria
- GSK Investigational Site Jos, Nigeria
NCT00436007
- Conditions
- Infections, Malaria, Malaria, Falciparum, +4 more
- Locations
-
- GSK Investigational Site Lambaréné, Gabon
- GSK Investigational Site Kintampo, Ghana
- GSK Investigational Site Dar es Salaam, Tanzania
NCT01936766
- Conditions
- Acute Kidney Injury, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +17 more
- Locations
-
- Chittagong Medical College Hosiptal Chittagong, Bangladesh
NCT01231503
- Conditions
- Infections, Malaria, Malaria, Falciparum, +4 more
- Locations
-
- GSK Investigational Site Bangwe, Blantyre, Malawi
Completed
Malaria Transmission Studies in Mali
NCT01829737
- Conditions
- Infections, Malaria, Malaria, Falciparum, +4 more
- Locations
-
- National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States
Completed
Malaria in Early Life Study
NCT02001428
- Conditions
- Infections, Malaria, Malaria, Falciparum, +7 more
- Locations
-
- Timika Research Facility Timika, Special Region of Papua, Indonesia
Completed
Safety And Immunogenicity Of Novel Candidate Blood-Stage Malaria Vaccine P27A : Phase Ia/Ib
NCT01949909
- Conditions
- Infections, Malaria, Malaria, Falciparum, +4 more
- Locations
-
- CHUV CRC Lausanne, Switzerland
- Bagamoyo Clinical Trial Unit (BCTU) Bagamoyo, Tanzania
Completed
ELISA Validation of Hypersensitive Rapid Diagnostic Test Results for Detection of P. Falciparum
NCT03132402
- Conditions
- Infections, Malaria, Malaria, Falciparum, +5 more
- Locations
-
- Shoklo Malaria Research Unit Mae Sot, Changwat Tak, Thailand